1-4 of 4
sulfadoxine
Close
Sort by
Journal Articles

Intermittent Use Of Sufadoxine-Pyrimethamine To Prevent Malaria In Patients With SCD In Malaria Endemic Regions: Findings From The Sickle Cell Disease Research and Control Center Of Bamako, Mali

Dapa Aly Diallo, MD, Aldiouma Guindo, PhD, Boubacari Ali Touré, MD, Yaya Sarro, PharmD, Baba Fané, MD, Alain Dorie, MD
Journal: Blood
Blood (2013) 122 (21): 1006.
https://doi.org/10.1182/blood.V122.21.1006.1006
Published: 2013
Journal Articles

Sickle-Cell Disease and Malaria: Evaluation of Seasonal Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine in Senegalese patients—a Randomized Placebo-Controlled Trial

Saliou Diop, MD, MSC, Moussa Seck, Youssou Bamar Gueye, Fabienne Soudre, Awa Oumar Touré Fall, Abibatou Sall, Doudou Thiam
Journal: Blood
Blood (2010) 116 (21): 1633.
https://doi.org/10.1182/blood.V116.21.1633.1633
Published: 2010
Journal Articles

Altered Immune Response in Severe Malaria Anemia in Children.

Victor R. Gordeuk, MD, Ishmael Kasvosve, PhD, Janneke van Dijk, MD, Guenter Weiss, MD, Zufan Debebe, MS, Sergei Nekhai, PhD, Thea Kuddo, MD, Philip E. Thuma, MD
Journal: Blood
Blood (2006) 108 (11): 1303.
https://doi.org/10.1182/blood.V108.11.1303.1303
Published: 2006
Journal Articles

Pyrimethamine Does Not Diminish Lymphoproliferation in MRL/lpr−/− Mice and Patients with Autoimmune Lymphoproliferative Syndrome (ALPS).

V. Koneti Rao, MD, Kennichi C. Dowdell, PhD, Faith Dugan, RN, Janet K. Dale, RN, MPH, Lesley Pesnicak, Lilia Bi, PhD, Scott Penzak, Pharm D, Nilo A. Avila, MD, Thomas A. Fleisher, MD, Jennifer M. Puck, MD, Stephen E. Straus, MD
Journal: Blood
Blood (2005) 106 (11): 2396.
https://doi.org/10.1182/blood.V106.11.2396.2396
Published: 2005